AMIRSYS® Announces PathIQ® ImmunoQuery® 2.10 Release

ImmunoQuery Reaches One Million Case Milestone!

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
ImmunoQuery 2.10 Based on 1,000,000 Cases
With this update, ImmunoQuery includes over one million cases derived from over 4,400 references.

Salt Lake City, UT (PRWEB) September 04, 2012

AMIRSYS, INC. announced today the update of its PathIQ ImmunoQuery product for pathologists. This update adds the latest and most important references to the expert and evidence-based decision support system for immunohistochemistry, representing well over 1,000,000 cases derived from over 4,600 references. Carefully selected by Amirsys’ team of experts, these updates provide 746 antibody classes with over 2,500 individual antibodies, and 480 diagnosis groups with over 1,900 individual diagnoses.

PathIQ ImmunoQuery 2.10 also adds improvements to enhance the user experience such as iPad compatibility, faster results, and better search performance including aliases and synonyms.

“This one million case milestone is a great accomplishment for PathIQ ImmunoQuery,” states Dennis M. Frisman, M.D., Associate Medical Editor at Amirsys Inc., and Founder of ImmunoQuery. “When I started this project, I never imagined that ImmunoQuery would become the world’s largest evidence-based pathology database and that it would be used by pathologists around the world.”

ABOUT AMIRSYS
Amirsys, Inc. is a leading provider of innovative healthcare solutions in radiology, pathology and medical education. Through use of its proprietary technology and image-intensive, expert-based content, Amirsys provides online problem-solving access to thousands of health professionals worldwide. Amirsys’ team of world renowned authors has created a unique content database. Resulting from this foundation, Amirsys has produced innovative products that dominate their respective markets.

For more information please visit http://www.immunoquery.com/.


Contact